sars cov 2 — grants

Sort

8,912 grants matching “sars cov 2”

Comprehensive genomic and inflammatory profiling of vaccine-associated myocarditis

$253,500

Amy R. Kontorovich · Icahn School Of Medicine At Mount Sinai · R21 · FY2023 · AI

Structural and metabolic neuroimaging of ME/CFS occurring with and without COVID-19 infection

$253,500

Xiang Xu · Icahn School Of Medicine At Mount Sinai · R21 · FY2022 · NS

Identification and characterization of gut microbial bioactive molecules that determine predisposition to autoimmune disease and atopy

$253,500

Jon Clardy · Harvard Medical School · R01 · FY2021 · AT

KY INBRE NOSI Supplement: Targeted COVID-19 Vaccine Decision Making Support for Sexual and Gender Minorities

$253,183

Martha E Bickford · University Of Louisville · P20 · FY2021 · GM

Rapid Genotyping of ApoL1 Risk Alleles using CRISPR-Cas12a

$253,103

Christopher P Larsen · Nephropathology Associates · R43 · FY2021 · DK

Modeling and data analysis of complex diseases

$252,978

Carson Chow · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK

Core B Clinical Core

$252,874

Tara F Carr · University Of Arizona · U19 · FY2022 · AI

Automation of Liquid Nitrogen Freezer for Cryopreservation of Unique Human Biospecimens at the Vanderbilt Biospecimen Storage Facility

$252,800

Alexander Bick · Vanderbilt University Medical Center · R24 · FY2023 · OD

Perturbing virus replication with interfering peptides

$252,749

Douglas J. Lacount · Purdue University · R21 · FY2022 · AI

Detection and Automatic Privacy-Protected Contact Tracing System Designed for COVID-19

$252,631

Xing Wang · University Of Illinois At Urbana-Champaign · U01 · FY2022 · AA

BIOREPOSITORY OPTIMIZATION AND USE FOR ENDOTYPING CRITICALLY ILL SARS-COV-2 INFECTED PATIENTS

$252,467

Leopoldo Nicolas Segal · New York University School Of Medicine · R21 · FY2022 · GM

Novel threat detection methodology to detect HIV outbreaks in Washington

$252,281

Roxanne Pieper Kerani · University Of Washington · R21 · FY2022 · AI

A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury

$252,208

John S Lazo · Kevirx Inc. · R43 · FY2021 · HL

mRNA-BASED VACCINE AGAINST MULTIPLE COVID-19 VARIANTS

$252,010

Mohammed Bouziane · Sunomix Therapeutics · R43 · FY2022 · IP

Effect of Ubiquitin D variants upon APOL1-mediated kidney injury

$252,000

Michael J Ross · Albert Einstein College Of Medicine · R21 · FY2024 · DK

Molecular analysis of glutamatergic neurons derived from iPSCs containing PPM1D truncating mutations found in Jansen de Vries Syndrome

$252,000

Herbert M Lachman · Albert Einstein College Of Medicine · R21 · FY2024 · MH

Correlating neutrophil function and plasma cytokine profiles with progression of ME/CFS and Long-Covid/PASC

$252,000

Felix Ellett · Massachusetts General Hospital · R21 · FY2023 · NS

Alterations and Renovations for Clinical Research Resources and Facilities

$251,843

Sally Lynn Hodder · West Virginia University · U54 · FY2022 · GM

Administrative Supplement: âMamma Miaâ: A multisite randomized controlled trial of an internet-based program for preventing and reducing perinatal depressive symptoms

$251,680

Patricia Anne Kinser · Virginia Commonwealth University · R01 · FY2021 · HD

Development and Characterization of Phage QBeta-Based SARS-CoV-2 RT-qPCR Assay Calibration Standards

$251,570

James E Kirby · Beth Israel Deaconess Medical Center · R21 · FY2025 · AI

Innovation Fund Application to the MACS/WIHS Combined Cohort Study (MWCCS): COVID-19 Vaccine Acceptance and Hesitancy (CVHB) Study in People with HIV

$251,550

Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2021 · HL

Kidney Microphysiological Analysis Platforms (MAP) to Explore SARS-CoV-2 Receptors and Inhibitors. A supplement to Parent Grant: Kidney Microphysiological Analysis Platforms (MAP) to Optimize Function

$251,531

Joseph Vincent Bonventre · Brigham And Women'S Hospital · UH3 · FY2020 · TR

Comprehensive genomic and inflammatory profiling of vaccine-associated myocarditis

Structural and metabolic neuroimaging of ME/CFS occurring with and without COVID-19 infection

Identification and characterization of gut microbial bioactive molecules that determine predisposition to autoimmune disease and atopy

Administrative Core

Administrative Core

RNA internal 2â-O methylation in SARS-CoV-2

KY INBRE NOSI Supplement: Targeted COVID-19 Vaccine Decision Making Support for Sexual and Gender Minorities

Rapid Genotyping of ApoL1 Risk Alleles using CRISPR-Cas12a

Modeling and data analysis of complex diseases

Core B Clinical Core

Automation of Liquid Nitrogen Freezer for Cryopreservation of Unique Human Biospecimens at the Vanderbilt Biospecimen Storage Facility

Perturbing virus replication with interfering peptides

Detection and Automatic Privacy-Protected Contact Tracing System Designed for COVID-19

BIOREPOSITORY OPTIMIZATION AND USE FOR ENDOTYPING CRITICALLY ILL SARS-COV-2 INFECTED PATIENTS

Novel threat detection methodology to detect HIV outbreaks in Washington

A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury

mRNA-BASED VACCINE AGAINST MULTIPLE COVID-19 VARIANTS

Effect of Ubiquitin D variants upon APOL1-mediated kidney injury

Molecular analysis of glutamatergic neurons derived from iPSCs containing PPM1D truncating mutations found in Jansen de Vries Syndrome

Correlating neutrophil function and plasma cytokine profiles with progression of ME/CFS and Long-Covid/PASC

Alterations and Renovations for Clinical Research Resources and Facilities

Administrative Supplement: âMamma Miaâ: A multisite randomized controlled trial of an internet-based program for preventing and reducing perinatal depressive symptoms

Development and Characterization of Phage QBeta-Based SARS-CoV-2 RT-qPCR Assay Calibration Standards

Innovation Fund Application to the MACS/WIHS Combined Cohort Study (MWCCS): COVID-19 Vaccine Acceptance and Hesitancy (CVHB) Study in People with HIV

Kidney Microphysiological Analysis Platforms (MAP) to Explore SARS-CoV-2 Receptors and Inhibitors. A supplement to Parent Grant: Kidney Microphysiological Analysis Platforms (MAP) to Optimize Function

RNA internal 2â-O methylation in SARS-CoV-2

Administrative Supplement: âMamma Miaâ: A multisite randomized controlled trial of an internet-based program for preventing and reducing perinatal depressive symptoms